Clustered interventions to reduce inappropriate duplicate laboratory tests in an Irish tertiary hospital. by Brady, Hugh et al.
Accepted Manuscript
Clustered interventions to reduce inappropriate duplicate
laboratory tests in an Irish tertiary hospital
Hugh Brady, Laura Piggott, Suzanne S. Dunne, Nuala H.
O'Connell, Colum P. Dunne
PII: S0009-9120(17)30632-X
DOI: doi:10.1016/j.clinbiochem.2017.10.012
Reference: CLB 9645
To appear in: Clinical Biochemistry
Received date: 26 June 2017
Revised date: 6 October 2017
Accepted date: 18 October 2017
Please cite this article as: Hugh Brady, Laura Piggott, Suzanne S. Dunne, Nuala H.
O'Connell, Colum P. Dunne , Clustered interventions to reduce inappropriate duplicate
laboratory tests in an Irish tertiary hospital. The address for the corresponding author was
captured as affiliation for all authors. Please check if appropriate. Clb(2017), doi:10.1016/
j.clinbiochem.2017.10.012
This is a PDF file of an unedited manuscript that has been accepted for publication. As
a service to our customers we are providing this early version of the manuscript. The
manuscript will undergo copyediting, typesetting, and review of the resulting proof before
it is published in its final form. Please note that during the production process errors may
be discovered which could affect the content, and all legal disclaimers that apply to the
journal pertain.
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
 
Clustered interventions to reduce inappropriate duplicate laboratory tests in an Irish tertiary hospital. 
 
 
Hugh Brady 1, Laura Piggott 2, Suzanne S. Dunne 2, Nuala H. O’Connell 2, 3, Colum P. Dunne 2* 
 
1  Finance Department, University Hospital Limerick, Dooradoyle, Limerick. 
2 Centre for Interventions in Infection, Inflammation & Immunity (4i) and Graduate-Entry Medical 
School, University of Limerick, Limerick. 
3 Clinical Microbiology, University Hospital Limerick, Dooradoyle, Limerick. 
 
 
 
*Corresponding author: 
Professor Colum Dunne 
Graduate Entry Medical School 
University of Limerick 
Limerick 
Ireland 
Email: colum.dunne@ul.ie  
Tel: +353 61 234703  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
Abstract 
 
Background 
There is increasing emphasis on understanding the rate, and avoidable costs, of inappropriate 
laboratory testing in hospitals, especially associated with duplication of tests following transfer of 
patients from one hospital to another. While studies of inappropriate testing have been reported 
previously, there are no published data relevant to Ireland. 
 
Aims 
To determine the baseline rate of inappropriate testing for a subset of clinical parameters, 
specifically, full blood counts (FBC), biochemistry profiles (Bio) and coagulation (Coag) screens for 
geriatric patients transferring to and from University Hospital Limerick (UHL). Prospective pilot-scale 
implementation of five clustered interventions, and assessment of their effect.  
 
Methods 
Baseline testing levels were determined between October 2013 and January 2014. A patient survey 
was conducted to evaluate patient awareness of the blood tests they underwent. Five interventions 
were trialled sequentially each month between January and May 2014. These included: educational 
poster, intern training, presentations and communication to consultants; automated prompt in the 
Lab Information Technology system; highlighting of patient survey results to medical staff; inclusion 
of laboratory test details on patient transfer document; patient booklet promoting empowerment. 
Impact was assessed by determining rates of inappropriate laboratory testing monthly, and 
associated actual cost reductions were calculated.  
 
Results 
Approximately two-thirds of geriatric inpatients were unaware of why they underwent blood tests. 
Baseline numbers of inappropriate duplicate FBCs, Bio profiles and Coag tests were 758, 749 and 
268 respectively for patients transferring to and from UHL. Following the interventions, these 
numbers dropped to 85, 84 and 0, respectively. 
 
Conclusion 
The interventions resulted in sustained reduction in rates of inappropriate testing by May 2014. 
Extrapolated cost reductions exceed two million Euro annually. The most effective intervention 
involved staff education.  
 
Keywords: Inappropriate laboratory testing; laboratory test utilization; test ordering practices; cost 
reduction; tertiary hospital 
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Introduction 
 
The Irish Government has implemented a funding model for hospitals known defined as Activity-
Based Funding (ABF), formerly “Money Follows the Patient”, representing a considerable 
modification of the mechanism by which hospitals are funded [1, 2]. In January 2014, this policy 
came into force for 38 of the state’s largest public hospitals’ inpatient and day case activity.  The 
policy replaces the previous arrangement of block grant allocation and, as elsewhere [3], places an 
emphasis on specific episodes of care, adjusted as appropriate for complexity of cases. Two 
specific outcomes of this model of funding are an increased vigilance regarding “cost per case” and 
a keen focus on the economic evaluation of procedure and processes. Such focus, however, is not 
specific to Ireland and has been described in reports from other countries where this model has 
been adopted, e.g., with reference to Medicare in the USA and the UK’s National Health Service 
(NHS) [4, 5]. 
 
In the context of economic scrutiny, therefore, it is not surprising that clinical laboratory testing, as 
the highest volume medical activity in hospitals [6], has become a focus of cost-reducing initiatives. 
Performing a thorough history and physical examination are necessary to formulate possible 
differential diagnoses. Furthermore, at least 10% of diagnoses are not considered final until clinical 
laboratory testing is complete [7-9]. That said, however, laboratory test overutilization has been the 
focus of multiple studies internationally as they can increase costs, lead to unnecessary 
investigations, and may have a negative impact on patient outcomes [10, 11]. 
 
Such international studies include recent publications that have highlighted the challenges 
associated with laboratory overutilization or inappropriate laboratory testing. Specifically, in 2017, 
Chemi et al [12] reported rates of inappropriate laboratory investigations of up to 20% between 
2006-2010 in Ontario, defined as testing >2 weeks prior to the minimum threshold to reorder defined 
by practice guidelines, and noted that up to 85% of the time the ordering physician of an 
inappropriate test was the same physician who ordered the previous appropriate test. Further data 
from 103,000 Canadian patients, provided by Morgan & Naugler (2015) [13], showed an 
inappropriate testing rate of 16% in Calgary, while in 2016, Meidani et al [14] detailed incidence of 
26.4% in Iran. The most comprehensive study of the subject, compiled by Zhi et al in 2013 [15] from 
a 15 year meta-analysis of international literature demonstrated laboratory over- and underutilization 
rates of 20.6% (95% CI 16.2-24.9%) and 44.8% (95% CI 33.8-55.8%), respectively, with the latter 
being greatly more under-studied. 
 
In light of these relatively high rates of lab over-use, it is perhaps unsurprising that the excellent 
review by Kobewka et al in 2015 [16] evaluated 109 eligible papers, published between 1946 and 
2013, detailing interventions for reduction of unnecessary tests. Although of varying quality, these 
interventions were identified as belonging to one or more non-exclusive category of education, audit 
and feedback, system based, or incentive or penalty. Results ranged from a 99.7% reduction to a 
27.7% increase in test use. The authors noted that numerous studies use low investment strategies 
to reduce test utilization and recommended that it was these low investment strategies that may be 
the most promising for achievable and durable reductions in inappropriate test use. 
 
Malone (2013) [17] described interventions that asked physicians not to order blood counts and 
metabolic panels if they did not have a specific indication in mind. Varying complementary 
reinforcements were employed: posters displayed in the Intensive Care Unit listing acceptable 
indications for FBCs and electrolyte tests; doctors were educated; prompts were added to order 
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systems for lab tests reading, e.g., “please do not order without an indication”. The approaches were 
rewarded with reductions overall of up to 24%, with patient safety and quality of care unaffected 
adversely.  
 
Based on anecdotal evidence of lab test over-utilization of lab tests, similar to that discussed by 
Stewart et al (2010) [18] whereby 32% of medical inpatients transferring between hospitals were 
subjected to inappropriate duplicate testing, the objective of our quality improvement project was to 
assess and to attempt reduction of inappropriate duplicate laboratory testing of acutely unwell 
geriatric medical patients transferred to and from University Hospital Limerick (UHL). Wishing to 
utilize low investment tactics, we choose to assess the impact of a series of interventions modeled 
on the Malone’s previously described successful approach.  
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Methods 
 
Setting and Patients 
The University Hospital Limerick Group consists of the University Hospital Limerick (UHL); Ennis 
General Hospital; Nenagh General Hospital; St John's Hospital Limerick; the University Hospital 
Maternity Hospital and Croom Hospital. UHL provides 24/7 acute surgery, acute medicine, and 
critical care, as well as tertiary care. The other five hospitals provide the majority of hospital activity 
including extended day surgery, selected acute medicine, local injuries and a range of diagnostic 
services. The hospital group serves a population of circa 400,000 people. 
 
Patients transferring between UHL and three of the University Limerick Group hospitals, namely 
Nenagh General Hospital, Ennis General Hospital and St John’s Hospital admitted under the 
Geriatric Teams as part of the General Medical Take were included. 
  
Ethical approval  
Ethical approval to complete this study was granted by the Health Service Executive (HSE) 
University of Limerick Hospitals Group Research Committee. 
 
Laboratory testing 
The focus was on potential duplicate lab tests occurring in patients transferring within UHL Group on 
day of transfer, specifically full blood count (FBC) (also referred to as a complete blood count – 
CBC), biochemistry profile (Bio) and Coagulation tests (Coag). Thyroid function tests (TFTs), 
hematinic (B12, ferritin, folate) and serum protein electrophoresis (SPEP) were also evaluated. 
SPEP may include immunoglobulin A, G and M (IgA, IgG and IgM) tests. Laboratory managers and 
the hospital group finance department provided laboratory costs. In the absence of interventions 
(e.g., blood transfusions), tests were considered inappropriate duplication according to the following 
criteria: TFTs – repetition within a four week period based on recommendations in “The UK 
Guidelines for the Use of Thyroid Function Tests” produced by the Association of Clinical 
Biochemistry and the British Thyroid Association and the British Thyroid Foundation (2006); 
hematinic - repetition within an eight-week period based on a study published in the International 
Journal of Laboratory Hematology (2011); SPEP - repetition within an eight week period; 
immunoglobulins - repetition within eight weeks. 
 
Determining baseline levels of laboratory testing was performed between October 2013 and January 
2014. Specifically, patients transferred to and from UHL under the care of the Geriatric consultants 
on General Medical Take were identified by Bed Management in the hospitals. Each patient’s name, 
date of birth, medical record number (MRN) and the date of transfer were recorded. The time 
between testing and admitting or discharge diagnosis were documented and the following data were 
then collected for each patient: transferring and accepting consultants; diagnosis; FBCs; Bio profiles 
and Coag screens done (on the day of transfer in the transferring hospital and in accepting 
hospital); TFTs; hematinic and SPEP tests done in the transferring and accepting hospitals; and the 
duration of time between repeat tests. All of the listed laboratory results were reviewed by a clinician 
to determine if inappropriate duplicate testing was evident.  
 
Interventions 
Prior to initiation of the interventions, in January 2014, a qualitative patient survey was designed, 
validated by pilot trialing using clinical staff, and conducted in conjunction with the Patient Advocacy 
Service to gauge patients’ experience of blood testing in UHL and their awareness of the purpose 
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for those tests.   The survey was conducted face to face and involved a semi-structured interview of 
20 consecutive patients encountered on transfer to UHL. 
 
The interventions were introduced sequentially, monthly from January to May 2014 (Figure 1). 
Laboratory testing was analyzed retrospectively monthly to determine the effect of each intervention. 
 
 
Intervention 1: Poster/educational intervention - Posters regarding inappropriate re-testing of 
FBC, Bio profile and Coag were displayed prominently in the Emergency Departments of University 
Hospital Limerick Group. We were unable to gauge what proportion of ordering clinicians saw the 
posters. However, flyers regarding inappropriate re-testing of TFTs, hematinic, SPEP and 
immunoglobulins were placed in the phlebotomy folders, which are available in all clinical areas.   
Intervention 2: Presentation/educational intervention - A Grand Rounds presentation to highlight 
the issue of inappropriate duplicate testing was given, targeting medical consultants, registrars and 
senior house officers. Grand Rounds are open to all clinicians within the University Hospital Limerick 
Group and are provided at the main University Hospital site. We were unable to estimate the 
percent attendance versus ordering clinicians. However, additional presentations were made at 
Medical Intern Training to highlight the issue and communication was sent electronically to the 
Medical Team members official email addresses to alert for inappropriate duplicate testing.  
Intervention 3: Lab Information Technology system review – Laboratory staff introduced a 
prompt in the Lab IT system for minimum recommended intervals for repeat testing. This occurred 
on request of an order for a test that had been requested previously (if within the repeat period). 
Staff then decided whether or not to proceed with the test. The requesting clinician had to be 
informed if the test was not performed. Where the clinician believed there was a compelling reason 
to do so, they could overrule the laboratory staff and the test could be performed. 
Intervention 4: Patient empowerment – The patient survey results were reviewed and a poster to 
inform all doctors and phlebotomy staff of the key results was displayed prominently. In addition, a 
HSE-produced leaflet was adapted to include a section describing common blood tests and made 
available to inpatients.  
Intervention 5: Modification of the transfer letter - Discharge/Transfer/Referral Communication 
documentation and ISBAR patient transfer communication tool was reviewed and adjusted to 
include a section on lab tests performed during the inpatient stay and on the day of transfer. ISBAR 
is a HSE-recommended tool to remind staff how to communicate effectively, what key questions to 
ask, and what information to provide in clinical situations, such as transferring of patients. The 
ISBAR tool originated from the US Navy and was adapted for use in healthcare by Dr M Leonard 
and colleagues from Kaiser Permanente, Colorado, USA.  
 
 
 
 
 
Results 
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Patient survey 
Twenty patients were surveyed as that was the number of patients (in the care of the geriatric 
department) transferred on a single random day who experienced interaction with the phlebotomy 
service. The survey was anonymized and their age, gender, and reason for hospitalization was not 
recorded. Each of the participating patients recalled having blood samples taken, with 18 of the 20 
remembering whether a doctor (9/18) or phlebotomist had performed the venipuncture.  Only 7/18 
patients understood why their blood was collected with two of those having asked the question of 
the phlebotomist. Common comments made by the remaining patients were similar to “assumed it 
was procedure” and; “they wouldn’t have taken it if they didn’t want it.” Seven patients mentioned 
having multiple samples drawn on a single day, while four patients recognized that they had 
samples collected on multiple times on a single day for the same test. It is especially noteworthy that 
11/20 patients were comfortable that staff explained to them, at least to some degree, why they 
were performing procedures on them including venipuncture and that, generally, the explanations 
were understandable. Eight patients believed that not enough information had been provided to 
them, with one stating that “staff are not concerned about questions”.  
 
 
Review of baseline levels of inappropriate laboratory testing 
Between October 2013 and January 2014, a review of the two lab information systems used within 
the UHL group (Agilent’s iLab and Custom Software’s NetAquire) determined an almost perfect 
correlation between performance of FBC and Bio profile screens, suggesting that they were almost 
always ordered together. During the initial review period, between 60 – 85% of patients transferred 
to UHL underwent FBC and Bio tests, with between 40 – 63% undergoing Coag screens. Of 
patients transferred from UHL, approximately 70% consistently underwent FBC and Bio tests, with 
<40% undergoing Coag screens. During the baseline review period, up to 80% of patients who 
transferred to UHL and had FBCs and Bio profile screening performed were subject to inappropriate 
duplicates (Figure 2a). Inappropriate Coag testing peaked at less than 65%. In both cases, the 
maximum rate of lab over-utilization occurred in December, correlating with recognized peaks in 
geriatric medical cases in the winter months. In contrast, when patients transferred from UHL to the 
other group hospitals, the levels of inappropriate FBC, Bio and Coag testing never exceeded 50% of 
that seen when the patient journey was reversed. Peak numbers were again in December (Figure 
2b).  
Inappropriate duplication of TFT and hematinic tests were seen on transfer from UHL (maximum 
25% and 40%, respectively) and on transfer to UHL (50% and 40%, respectively). However, there 
was no inappropriate SPEP testing identified at any point in this study. 
In summary, 720 patients transferred to UHL resulting in 1035 unnecessary tests, while 1929 
patients transferred from UHL resulting in 1400 unnecessary tests. A breakdown of these numbers 
across the testing criteria is provided in Table 1.  
In reviewing the patient records, other notable features of the systems were identified: the lack of a 
single shared IT system across the hospital group meant that attending physicians and laboratory 
staff were unable to access all patient records; patients did not have a single consistent MRN and 
each hospital issued a new MRN on admission; transferred patients were not accompanied by their 
blood test results and transfer letters did not consistently refer to tests or provide results of same; as 
the lab test ordering system was paper-based, duplicate tests for patients were not “flagged”. 
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Post-intervention levels of inappropriate laboratory testing 
Overall, implementation of the series of interventions was successful. The levels of inappropriate 
FBC, Bio and Coag tests performed on patients transferring to UHL decreased from a maximum of 
80% to 14%, 80% to 14%, and 65% to 0%, respectively between January and May 2014 
representing a total of 170 tests (Figure 2a). Similarly, the levels of inappropriate FBC and Bio tests 
performed on patients transferring from UHL decreased from a maximum of 38% to 0%, while 
inappropriate Coag tests reduced from 22% to zero representing a total of 169 tests (Figure 2b).  
Over the course of the interventions, inappropriate TFT and Hematinic testing of patients 
transferring to UHL decreased from 57% to zero and 40% to zero, respectively. For patients 
transferring to UHL, the observed reductions were 25% to 8% and 20% to 11%, respectively. In all 
cases, these reductions have been maintained since May 2014.  
In assessing the impact of each individual intervention, it was notable that following each there was 
a decrease in inappropriate testing with the exception of Intervention 2, after which patients 
transferred from UHL underwent increased Coag tests. This has not been correlated with any 
specific microbiology outbreak or other cause, and was transient. In obtaining feedback from 
participating clinicians, the intervention most commonly referred to was Intervention 2. However, this 
was also the Intervention that was referred to as having most limitiations, namely: not all targeted 
clinicians may have attended the intern traing presentations or Grand Rounds; not all staff clinicians 
routinely use their hospital email addresses and, therefore, may not have read the emails regarding 
inappropriate testing; it is impossible to know how may clincians say and/or acted on the information 
displayed on the posters. 
Similarly, following Intervention 4, patients transferred to UHL underwent increased Bio profiles, 
albeit that the increased number did not reach pre-intervention numbers from January. Again the 
increased testing was transient.  
 
Determining cost reductions.  
Over the course of these interventions, relating only to the cohort of geriatric patients transferred to 
and from UHL, the total number of inappropriate tests avoided exceeded two thousand (Table 2). 
Coordination between the laboratory managers and the finance department calculated the savings 
at approximately €13,500. These costs were based on full economic costings incorporating time, 
equipment use, consumables and reagents. 
 
To determine the potential influence of the interventions across all transferred patients being cared 
for by all clinical specialties, we utilized the full year laboratory testing costs provided by the finance 
division of the hospital group based on actual tests performed and associated expenditure (Table 3). 
While the savings related to this current study were modest, projecting similar success for a full year 
and across disciplines would have resulted in reductions of between 115,462 and almost 388,000 
FBC, Bio, Coag, TFT and Hematinic tests. The associated savings were calculated as being 
between €717,848 and almost €2.9 million, based on 2013/2014 costs. 
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Discussion 
 
Laboratory tests appropriately play a role in modern medicine, and rapidly evolving molecular 
techniques expedite patient care and enhance outcomes [19 - 21]. However, there is 
acknowledgement of inappropriate, and over-utilization of, laboratory testing. In this context, a series 
of sequential interventions were implemented successfully in a mid-West of Ireland hospital group, 
resulting in reduction of unnecessary tests and generation of financial savings. Although performed 
in relation to a single medical discipline, geriatrics, and focusing on transfer patients only, 
extrapolation of the results across the scope of the hospital group activities projected multi-million 
Euro cost reductions.  
Our study focused on transferred geriatric patients from January to May 2014, resulting in savings of 
approximately €13,500. However, while the observed effect was modest, extrapolation of the cost 
reductions projected that if the interventions could be translated into similar success across the 
range of clinical disciplines and laboratory testing, meaningful budgetary savings of between 
€717,848 and almost €2.9 million could be made. The potential consequence of the interventions, 
however, would be evident beyond financial planning as clincial workload, patient management, and 
laboratory resource utilisation would also benefit considerably. 
 
Evaluating the series of interventions, and their separate relative contributions to the successful 
reductions seen, proved difficult due to considerable monthly variations (Figures 2a and 2b) in the 
patient cohort and complexity of their testing requirements. A limitation of this study, and a challenge 
in interpreting the impact of the interventions, is that determination of the individual success or 
failure of any intervention would require repetition of the exercise over a number of years, correcting 
for seasonality and patient demographics. That said, however, it appears evident that first two 
interventions, both educational in nature, caused initial decreases in unnecessary lab tests. As 
these interventions were not repeated in later months, and as the resulting decreases were 
sustained subsequently, it is reasonable to argue that the latter three interventions caused both 
confirmation in behavioral changes related to lab test requests and consolidated that modification. 
These are reasonable arguments, as our experience closely mirrors beneficial outcomes of such low 
investment approaches described by Malone previously [17], specifically education- and awareness-
based intervention. Such strategies may be attractive to hospitals attempting to achieve 
improvements without requirement for significant resource allocations. However, given the turnover 
of clinical staff (and patients) in most healthcare facilities, such interventions may require repetition 
and sustained focus for long-term success. For that reason, interventions to reduce inappropriate 
lab testing have tended to concentrate on test-ordering IT systems and / or associated patient-
related documentation. Therefore, our intervention involved the inclusion of prompts in the ordering 
system to highlight recent tests and to query requirement for repetition. Prompted by the benefit 
seen in modifying the information technology, in 2015 an integrated patient management system 
was implemented facilitating a unique patient identifier MRN for each patient within the UHL hospital 
group and, thus, reducing a further identified barrier to efficient lab testing.  
To our knowledge, this is the first report analyzing influence of such interventions in Ireland on both 
the actual burden of laboratory testing in addition to financial impact. However, this topic is of 
concern internationally with previous papers having described cost-saving exercises focused on 
reduction of laboratory tests in: South Africa [22], where a study of 320 patients over four weeks in 
identified €5,500 of avoidable test-related costs; in the USA, the “choose wisely” campaign [23] 
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demonstrated cost savings of $290,000 over 2 years relating to Centers for Medicare and Medicaid 
Services; also in the USA, an intervention to reduce costs associated with duplication of B-Type 
Natriuretic Peptide tests delivered approximately $92,000 per year [24]; while a 2016 Spanish report 
[25] described excessive requests for total bilirubin (tBil) testing and an intervention that netted 
$9825.50 in savings over two years.  
A reflection of the continuing international focus on laboratory cost reductions and appropriate 
resource utilization, and indeed an indication of the generalizability of our study, is the fact that 
during the time since our study was performed, interventions with analogous outcomes have been 
reported from the USA [23, 24, 26] and Italy [27, 28]. However, it is the Canadian intervention 
described by Gottheil et al in 2016 [29] that perhaps most closely resembles our work in combining 
educational activities and complementary modifications to the IT system that successfully generated 
a reduction of 40% reduction on lab over-utilization, results that are comparable with our outcomes. 
We would, therefore, suggest that future interventions involve combination of repeated and 
consistent raising of awareness among those responsible for ordering tests, patients undergoing 
tests and their families, complemented by provision of prompts integrated within the IT system.   
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Tables and Figures 
 
 
Figure 1. Design and timing of the quality improvement interventions. 
 
 
Oct-Jan	
• Baseline	data	collec on	of	inappropriate	duplicate	tests	for	transferring	pa ents	
Early	Jan	
• Pa ent	survey	
End	Jan	
• Educa onal	poster	re	duplicate	tes ng	(INTERVENTION	TIMEPOINT	1)	
Feb	
• Intern	training	and	grand	rounds	presenta on	on	duplicate	tes ng	
• Communica on	to	consultants	re	duplicate	tes ng	(INTERVENTION	TIMEPOINT	2) 		
March	
• Lab	prompt	re	minimal	intervals	introduced	
• Repeat	data	collec on	on	inappropriate	duplicate	tests	for	transferring	pa ents	(INTERVENTION	
TIMEPOINT	3)	
			April 		
• Repeat	data	collec on	on	inappropriate	duplicate	tests	for	transferring	pa ents	
• Pa ent	survey	results	poster	displayed	(INTERVENTION	TIMEPOINT	4)	
May	
• Repeat	data	collec on	on	inappropriate	duplicate	tests	for	transferring	pa ents	
• Inclusion	of	lab	tests	in	transfer	le er	
• Pa ent	booklet	made	available	(INTERVENTION	TIMEPOINT	5)	
June	
onwards	
• Roll-out	of	common	MRN	for	pa ents	within	the	group	
• Tendering	of	clinical	management	system	to	allow	lab	test	tracking	
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Figure 2a. Inappropriate testing of patients transferred to University Hospital Limerick (UHL) 
from other group hospitals (JENS)  
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Figure 2b. Inappropriate testing of patients transferred to other group hospitals (JENS) 
from University Hospital Limerick (UHL). 
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Table 1. Baseline number of patient transfers and associated laboratory testing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 FBC Bio Coag TFT Hematinic SPEP Total 
No. of patients transferred to UHL 720 
% of patients tested - No. in () 
% inappropriately tested 
No. of inappropriate duplicate tests 
 
83% (598) 
58% 
345 
 
82% (594) 
57% 
336 
 
 
55% (396) 
45% 
180 
 
48% (349) 
35% 
123 
 
33% (239) 
21% 
51 
 
14% (98) 
0% 
0 
 
 
 
1035 
No. of patients transferred from UHL 1929 
% of patients tested - No. in () 
% inappropriately tested 
No. of inappropriate duplicate tests 
 
Total No. of inappropriate duplicate tests 
to/from  UHL 
 
 
75% (1439) 
29% 
413 
 
758 
 
75% (1439) 
29% 
413 
 
749 
 
30% (588) 
15%  
88 
 
268 
 
58% (1119) 
25% 
284 
 
407 
 
35% (683) 
30% 
202 
 
253 
 
10% (199) 
0 
0 
 
0 
 
1400 
 
 
 
2435 
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Table 2.  Financial impact of interventions 
 
Impact of Interventions FBC Bio Coag TFT Hematinics SPEP Total 
        
Reduction in inappropriate testing 
per year 
673 665 268 313 177 - 2,096 
 
Reduction in costs per year (€) 
 
1,413 
 
4,954 
 
3,158 
 
1,880 
 
2,090 
 
- 
 
13,495 
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Table 3. Possible annual cost reductions (based on full year 2013)  
 
Impact of Interventions FBC Bio Coag TFT Hematinics SPEP TOTAL 
        
Reduction in inappropriate 
testing per year 
35,311-
140,906 
34,048-
133,602 
13,130-
40,181 
26,547-
54,694 
6,426-18,348 - 115,462-
387,731 
 
Reduction in costs per year 
(€) 
 
74,153-
295,902 
 
253,657-
1,576,504 
 
154,930-
474,132 
 
159,282-
328,164 
 
75,826-216,506 
 
- 
 
717,848-
2,891,208 
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Clustered interventions to reduce inappropriate duplicate laboratory tests in an Irish tertiary 
hospital. 
 
 
Hugh Brady 1, Laura Piggott 2, Suzanne S. Dunne 2, Nuala H. O’Connell 2, 3, Colum P. Dunne 2* 
 
 
Highlights: 
 There is increasing emphasis on understanding the rate, and avoidable costs, of 
inappropriate laboratory testing in hospitals. 
 There are no published data relevant to Ireland. 
 Pilot-scale implementation of five clustered interventions, and assessment of their effect. 
 Approximately two-thirds of inpatients were unaware of why they underwent blood tests. 
 Baseline rates of inappropriate testing for FBCs, Bio profiles and Coag screens were 29%, 
29% and 12%, respectively for patients transferring from large teaching hospital and 58%, 
57% and 45%, respectively, for patients transferring from that hospital. 
 The interventions resulted in sustained reduction in rates of inappropriate testing 
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